Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutation-Reference-Cited by-同舟云学术

Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutation

Published:2017-06-08 Issue:6 Volume:12 Page:e0178989
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Yanagida Satoshi^ORCID,Anglesio Michael S.,Nazeran Tayyebeh M.,Lum Amy,Inoue Momoko,Iida Yasushi,Takano Hirokuni,Nikaido Takashi,Okamoto Aikou,Huntsman David G.

Funder

Terry Fox Research Institute

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. Clinicopathologic characteristics of granulosa cell tumors of the ovary: A multicenter retrospective study;IH Lee;J Gynecol Oncol. Korean Society of Gynecologic Oncology and Colposcopy,2011

2. Primary cancer of the ovary An analysis of 349 cases;SW Kent;Am J Obstet Gynecol,1960

3. Clinical data of granulosa cell tumors;KW Schweppe;J Cancer Res Clin Oncol,1982

4. Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary;SP Shah;N Engl J Med,2009

5. Molecularly Defined Adult Granulosa Cell Tumor of the Ovary: The Clinical Phenotype;MK McConechy;J Natl Cancer Inst,2016

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An extensive immunohistochemical analysis of 290 ovarian adult granulosa cell tumors with 29 markers;Virchows Archiv;2024-06-21

2. The impact of the FOXL2 gene on ovarian granulosa cells KGN;2024-06-06

3. Adult-Type Ovarian Granulosa Cell Tumour: Treatment Outcomes From a Single-Institution Experience;Cureus;2022-11-03

4. The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial;Investigational New Drugs;2021-01-07

5. Ovarian sex cord-stromal tumors: an update on clinical features, molecular changes, and management;International Journal of Gynecologic Cancer;2021-01-07